全球药物滥用检测市场规模、份额、趋势和成长分析报告（2026-2034年）

预计药物滥用检测市场将从 2025 年的 16.2 亿美元成长到 2034 年的 26 亿美元，2026 年至 2034 年的复合年增长率为 5.38%。

由于全球药物滥用案件的增加和监管政策的日益严格，全球药物滥用检测市场正在显着扩张。各国政府和组织正在强制要求职场进行药物检测，以确保安全和合规性。阿片类药物成瘾的蔓延以及人们对药物滥用的认识不断提高，都推动了医疗保健、执法和企业等领域的市场稳步增长。

关键成长要素包括快速检测套组、免疫检测分析仪和实验室确认方法的技术进步。就地检验设备的普及提高了效率并缩短了出结果的时间。此外，路边毒品检测计画的扩展和毒理学实验室投资的增加，正在推动已开发国家和开发中国家的市场成长。

随着数位化整合和携带式侦测设备日趋成熟且价格更加亲民，市场前景依然强劲。復健设施的扩建和更严格的药品监管将进一步刺激需求。新兴市场由于医疗基础设施的改善和宣传宣传活动的发展，预计将迎来巨大的发展机会。总体而言，持续的政策支持和技术创新有望支撑市场的长期成长。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球药物滥用检测市场：依药物类型划分

• 市场分析、洞察与预测
• 精神兴奋剂
• 药品
• 大麻素
• 镇静剂
• 其他的

第五章 全球药物滥用检测市场：依技术类型划分

• 市场分析、洞察与预测
• 免疫检测
• 层析法
• 快速检测

第六章 全球药物滥用检测市场：依最终用户划分

• 市场分析、洞察与预测
• 医院
• 诊断检测实验室
• 法医科学研究所
• 其他的

第七章 全球药物滥用检测市场：按地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第八章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第九章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Abbott Laboratories（Alere Inc.）
  • F. Hoffmann La-Roche Ltd
  • Siemens AG（Siemens Healthineers）
  • Thermo Fisher Scientific Inc
  • Drgerwerk AG Co KGaA
  • Chromsystems Instruments & Chemicals GmbH
  • AccuBioTech Co. Ltd
  • Screen Italia Srl
  • Paramedical SRL
  • MP Biomedicals

The Drugs of Abuse Testing Market size is expected to reach USD 2.60 Billion in 2034 from USD 1.62 Billion (2025) growing at a CAGR of 5.38% during 2026-2034.

The Global Drugs of Abuse Testing Market is expanding significantly due to increasing substance abuse cases and strict regulatory policies worldwide. Governments and organizations are implementing mandatory workplace drug testing to ensure safety and compliance. The growing prevalence of opioid addiction and rising awareness regarding drug misuse are contributing to the market's steady growth across healthcare, law enforcement, and corporate sectors.

Major growth drivers include technological advancements in rapid testing kits, immunoassay analyzers, and laboratory-based confirmation methods. Increasing adoption of point-of-care testing devices has improved efficiency and reduced turnaround time. Additionally, expanding roadside drug testing programs and rising investments in toxicology laboratories are fueling market expansion in developed and developing regions alike.

Future prospects remain strong as digital integration and portable testing devices become more advanced and affordable. The expansion of rehabilitation centers and stricter anti-drug regulations will further boost demand. Emerging markets are expected to present significant opportunities due to improving healthcare infrastructure and awareness campaigns. Overall, consistent policy support and technological innovation will sustain long-term market growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Drug Type

• Psychostimulants
• Narcotics
• Cannabinoids
• Sedatives
• Others

By Technique Type

• Immunoassay
• Chromatography
• Rapid Testing

By End User

• Hospitals
• Diagnostics Laboratories
• Forensic Laboratories
• Others

COMPANIES PROFILED

• Abbott Laboratories Alere Inc, F Hoffmann LaRoche Ltd, Siemens AG Siemens Healthineers, Thermo Fisher Scientific Inc, Drgerwerk AG Co KGaA, Chromsystems Instruments Chemicals GmbH, AccuBioTech Co Ltd, Screen Italia Srl, Paramedical srl, MP Biomedicals
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL DRUGS OF ABUSE TESTING MARKET: BY DRUG TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Drug Type
• 4.2. Psychostimulants Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Narcotics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Cannabinoids Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Sedatives Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL DRUGS OF ABUSE TESTING MARKET: BY TECHNIQUE TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Technique Type
• 5.2. Immunoassay Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Chromatography Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Rapid Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL DRUGS OF ABUSE TESTING MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Diagnostics Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Forensic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL DRUGS OF ABUSE TESTING MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Drug Type
  • 7.2.2 By Technique Type
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Drug Type
  • 7.3.2 By Technique Type
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Drug Type
  • 7.4.2 By Technique Type
  • 7.4.3 By End User
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Drug Type
  • 7.5.2 By Technique Type
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Drug Type
  • 7.6.2 By Technique Type
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL DRUGS OF ABUSE TESTING INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Abbott Laboratories (Alere Inc.)
  • 9.2.2 F. Hoffmann La-Roche Ltd
  • 9.2.3 Siemens AG (Siemens Healthineers)
  • 9.2.4 Thermo Fisher Scientific Inc
  • 9.2.5 Drgerwerk AG Co KGaA
  • 9.2.6 Chromsystems Instruments & Chemicals GmbH
  • 9.2.7 AccuBioTech Co. Ltd
  • 9.2.8 Screen Italia Srl
  • 9.2.9 Paramedical S.R.L
  • 9.2.10 MP Biomedicals